Iran emerges as global fertility hub, blending innovation, research and scientific excellence

By Ivan Kesic

From pioneering research institutes to locally developed cutting-edge technologies, Iran has crafted a healthcare success story, emerging as a global leader in reproductive medicine and offering hope to millions of couples struggling with infertility. 

Decades of strategic investment and scientific dedication have positioned Iran among the world’s foremost authorities in infertility diagnosis and treatment.

The country’s achievements in this important medical field not only meet but often surpass the standards of many advanced countries, with success rates for Iranian couples better than global benchmarks.

As Professor Ashraf Moeini of the Iranian Fertility and Infertility Association said recently, Iran’s progress in diagnosing and treating infertility today matches that of developed countries, with no challenges.

This remarkable journey, beginning with foundational milestones in the late 1980s, is defined by groundbreaking indigenous innovation, most notably the localization of critical technologies such as embryo cryopreservation equipment, a feat accomplished by only a handful of nations.

Today, Iran’s advanced, cost-effective, and comprehensive care ecosystem not only serves its domestic population but also attracts a growing influx of international patients.

In doing so, the country has transformed into a global hub for reproductive health tourism, solidifying its reputation as a regional scientific powerhouse. 

Legacy of pioneering research and institutional excellence

Iran’s phenomenal rise to prominence in reproductive medicine can be traced to the vision and establishment of pioneering institutions in the years following the Islamic Revolution in 1979.

The creation of the Royan Institute in 1991, together with earlier initiatives such as the Yazd Infertility Research and Treatment Center, reflected a deliberate national commitment to confronting infertility through advanced science. 

These centers were far more than clinics. They evolved into integrated hubs of research, education, and patient care, cultivating generations of specialists in obstetrics, gynecology, urology, and reproductive medicine.

Their early breakthroughs — including the birth of Iran’s first IVF babies in the early 1990s — laid a formidable foundation for future progress. 

This institutional legacy continues to flourish. Royan is now recognized among the world’s top ten research institutions in male infertility and assisted reproductive technologies, consistently ranking as one of Iran’s leading scientific centers.

In parallel, the development of the Avicenna Research Institute further expanded national capacity, creating a robust network of expertise dedicated to delivering comprehensive diagnostic and therapeutic services for all causes of infertility.

Indigenous innovation driving accessibility and excellence

A cornerstone of Iran’s success story lies in its strategic pursuit of technological self-sufficiency, which has dramatically expanded access and reduced costs without compromising quality.

In a landmark achievement, Iranian knowledge-based companies localized the production of embryo cryopreservation equipment, making Iran only the fourth country worldwide — after Japan, Spain, and Canada — to master this complex technology.

The significance of this breakthrough is profound: domestically produced equipment performs at world-class standards yet costs just one-tenth of imported alternatives, ensuring advanced fertility preservation is accessible across the nation. 

This spirit of innovation extends across the entire treatment spectrum. Researchers have localized the production of more than 30 advanced infertility devices and diagnostic test kits, with some local products priced at merely one-fifteenth of foreign equivalents.

This concerted drive toward technological sovereignty has severed dependence on imports, conserved national resources, and, most importantly, placed cutting-edge treatment within financial reach of a far broader segment of the population, embodying a healthcare model that is both advanced and equitable. 

Comprehensive suite of world-class treatment modalities

Iran’s infertility treatment landscape offers a complete portfolio of advanced assisted reproductive technologies (ART), ensuring that virtually no couple is left without a pathway to parenthood.

Clinics across the country provide the full spectrum of services, from basic drug therapies and intrauterine insemination (IUI) to the most sophisticated in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) techniques. 

Within a clear legal and ethical framework established decades ago, Iran systematically offers alternative treatments such as egg donation, sperm donation, embryo donation, and surrogacy, solutions for even the most complex cases.

Equally impressive is the integration of genetic medicine into reproductive care.

Using advanced techniques like Preimplantation Genetic Diagnosis (PGD) and Next-Generation Sequencing (NGS), specialists can screen embryos for genetic disorders before implantation, prevent the transmission of hereditary diseases such as thalassemia and hemophilia, and perform HLA typing to enable the birth of a sibling who can serve as a stem cell donor for an older child in need. 

This seamless integration of cutting-edge genetics ensures not only the possibility of pregnancy but also the promise of a healthy child, underscoring Iran’s position at the forefront of reproductive medicine. 

Pioneering regenerative and advanced therapies

Iranian researchers are not simply applying global standards, they are actively pushing the boundaries of reproductive science, particularly in the promising field of regenerative medicine.

At leading institutes such as Royan, investigative work is exploring the use of stem cells to treat conditions once considered insurmountable barriers to fertility. 

Groundbreaking clinical research is underway to harness stem cells in treating premature ovarian insufficiency, with the potential to restore ovarian function and fertility in women experiencing early menopause.

Parallel efforts are focused on using stem cell therapies to repair severe intrauterine adhesions, a condition that damages the uterine lining and prevents embryo implantation. These approaches aim to restore the uterus’s natural receptivity and open new pathways to pregnancy. 

Though still in development and clinical trial phases, these innovations represent the vanguard of infertility treatment. They underscore Iran’s role as a contributor to global medical knowledge, moving beyond application into the realm of original discovery and therapeutic innovation. 

Destination for health tourism: International recognition and trust

The convergence of high-quality care, comprehensive services, and remarkable cost-effectiveness has positioned Iran as a premier global destination for infertility treatment, drawing patients from across the region and beyond. 

The cost advantage is striking: while a single IVF cycle can cost $10,000–$15,000 in developed countries and $5,000–$6,000 in other West Asian countries, the same high-quality treatment is available in Iran for under $1,000 for citizens and remains highly competitive for international patients.

Coupled with success rates comparable to leading European and American health centers, this affordability and high quality has created a powerful global draw. 

Iranian clinics now routinely welcome patients from more than 160 countries, with significant numbers arriving from Iraq, Afghanistan, Tajikistan, Armenia, Pakistan, Turkey, Persian Gulf states, and even Europe.

Dedicated international patient departments and culturally sensitive care teams further enhance the experience, translating clinical excellence into a thriving health tourism sector. This not only generates revenue but also strengthens Iran’s reputation and goodwill on the international stage. 

A respected player on global research stage

Iran’s clinical accomplishments are firmly anchored in a robust and respected body of scientific research, earning the country a distinguished reputation in global academic circles.

Scientometric analyses reveal that Iran ranks third worldwide — after only China and the United States — in the production of scientific articles on reproductive medicine. In terms of research impact, measured by citations, Iran holds an impressive eighth place globally, outperforming its overall standing in clinical medicine.  

Within the region, Iran is unequivocally the leader, ranking first in West Asia for reproductive medicine publications.

Esteemed researchers from institutions such as Tehran University of Medical Sciences, the Royan Institute, and Shahid Beheshti University are frequently published in and cited by international journals.

This prolific and influential output demonstrates that Iran’s medical community is not only a participant but a valued contributor to the global scientific dialogue, offering novel insights and advancing studies that help shape the future of reproductive medicine worldwide. 

Integrating treatment into societal health and development

The advancement of infertility services in Iran is supported by a coherent national policy framework that recognizes reproductive health as integral to societal well-being.

Legislative measures, such as the Law on Protection of the Family and Youth of the Population, reflect a deep commitment to supporting family formation. 

In a landmark move to reduce financial barriers, the government has mandated insurance coverage for infertility treatments, subsidizing up to 90 percent of costs for eligible couples.

This ensures that economic status does not preclude access to care, allowing families from all socioeconomic backgrounds to benefit from the nation’s medical advancements. 

By systematically integrating advanced infertility treatment into the public health agenda, Iran is not only addressing a pressing medical need but also contributing to broader social goals, supporting the dreams of countless couples and fostering a vibrant, hopeful society.

The country’s journey in reproductive medicine thus stands as a holistic model, where scientific ambition, technological ingenuity, and compassionate policy converge to create a lasting legacy of life and hope. 

Press TV’s website can also be accessed at the following alternate addresses:

www.presstv.co.uk